BRCA2 and ovarian cancer: Given the ineffectiveness of screening for ovarian cancer, prophylactic risk-reducing salpingo-oophorectomy (RRSO) is recommended between the ages of 35 and 40 for BRCA1 carriers and between the ages of 40 and 45 for BRCA2 carriers (NCCN 2023).